Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial

…, GV Long, R Kurzrock, KB Kim, TH Arkenau, MP Brown… - The Lancet, 2012 - thelancet.com
Background Dabrafenib is an inhibitor of BRAF kinase that is selective for mutant BRAF. We
aimed to assess its safety and tolerability and to establish a recommended phase 2 dose in …

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

…, S Lo, S Sandhu, AD Guminski, MP Brown… - The Lancet …, 2018 - thelancet.com
Background Nivolumab monotherapy and combination nivolumab plus ipilimumab increase
proportions of patients achieving a response and survival versus ipilimumab in patients with …

[BOOK][B] Closet space: Geographies of metaphor from the body to the globe

MP Brown - 2005 - taylorfrancis.com
… By situating the closet in different locations and at different spatial scales, Michael P. Brown
shows how its iterations have implications for a wide array of contemporary social theories …

[BOOK][B] Replacing citizenship: AIDS activism and radical democracy

MP Brown - 1997 - books.google.com
This book uses an ethnographic study of one gay community's responses to AIDS to illustrate
a radical democratic understanding of citizenship in contemporary society. Analyzing …

[HTML][HTML] The inducible caspase-9 suicide gene system as a “safety switch” to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells

T Gargett, MP Brown - Frontiers in pharmacology, 2014 - frontiersin.org
Immune modulation has become a central element in many cancer treatments, and T cells
genetically engineered to express chimeric antigen receptors (CAR) may provide a new …

[HTML][HTML] A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer

JD Mellor, MP Brown, HR Irving, JR Zalcberg… - Journal of hematology & …, 2013 - Springer
Antibody-dependent cellular cytotoxicity (ADCC) is a major mechanism of action of therapeutic
monoclonal antibodies (mAbs) such as cetuximab, rituximab and trastuzumab. Fc gamma …

[HTML][HTML] GD2-specific CAR T cells undergo potent activation and deletion following antigen encounter but can be protected from activation-induced cell death by PD-1 …

…, JD Hayball, ID Lewis, MK Brenner, MP Brown - Molecular Therapy, 2016 - cell.com
Chimeric antigen receptor (CAR) T cells have shown great promise in the treatment of
hematologic malignancies but more variable results in the treatment of solid tumors and the …

[HTML][HTML] Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?

AH Staudacher, MP Brown - British journal of cancer, 2017 - nature.com
Antibody drug conjugates (ADCs) employ the exquisite specificity of tumour-specific monoclonal
antibodies (mAb) for the targeted delivery of highly potent cytotoxic drugs to the tumour …

Prudentius' Contra Symmachum, book II introduction, translation and commentary

MP Brown - 2003 - theses.ncl.ac.uk
Prudentius' Contra Symmachum contains a refutation of Symmachus' plea for the retaining
of the altar of Victory in the Senate house at Rome which had been removed in 357 and then, …

Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease

P Brown, CJ Gibbs Jr… - Annals of Neurology …, 1994 - Wiley Online Library
We present a synthesis of clinical, neuropathological, and biological details of the National
Institutes of Health series of 300 experimentally transmitted cases of spongiform …